Wellmesen and colleagues analyzed the association between RHOA mutational status and other recurrent mutations using the data from large sequencing studies and proposed three potentially AITL lymphomagenic pathways. This evidence concerns the gene RHOA and angioimmunoblastic T-cell lymphoma.